Kashiv BioSciences and Intas Pharmaceuticals Enter Exclusive Licensing Pact for Complex Peptide in Europe, UK and India
MM Desk
14 February, 2026
Kashiv BioSciences has entered into an exclusive licensing and supply agreement with Intas Pharmaceuticals for
